Segment disclosures

Company overview

STRATA SKIN SCIENCES, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

125 dimension combinations 718 retained observations 46 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · CN · Dermatology Procedures Equipment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-313355000 USD20260326Open filing evidence
2025-07-01 – 2025-09-30130000 USD20251114Open filing evidence
2025-01-01 – 2025-09-302623000 USD20251114Open filing evidence
2025-04-01 – 2025-06-301659000 USD20250814Open filing evidence
2025-01-01 – 2025-06-302493000 USD20250814Open filing evidence
2024-01-01 – 2024-12-314069000 USD20260326Open filing evidence
2024-07-01 – 2024-09-301045000 USD20251114Open filing evidence
2024-01-01 – 2024-09-303165000 USD20251114Open filing evidence
2024-04-01 – 2024-06-301018000 USD20250814Open filing evidence
2024-01-01 – 2024-06-302120000 USD20250814Open filing evidence

Operating Segments · CN · Dermatology Recurring Procedures

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-310 USD20260326Open filing evidence
2025-07-01 – 2025-09-300 USD20251114Open filing evidence
2025-01-01 – 2025-09-300 USD20251114Open filing evidence
2025-04-01 – 2025-06-300 USD20250814Open filing evidence
2025-01-01 – 2025-06-300 USD20250814Open filing evidence
2024-01-01 – 2024-12-310 USD20260326Open filing evidence
2024-07-01 – 2024-09-300 USD20251114Open filing evidence
2024-01-01 – 2024-09-300 USD20251114Open filing evidence
2024-04-01 – 2024-06-300 USD20250814Open filing evidence
2024-01-01 – 2024-06-300 USD20250814Open filing evidence
2023-01-01 – 2023-12-310 USD20250328Open filing evidence

Operating Segments · KR · Dermatology Procedures Equipment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:KR;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-312055000 USD20240328Open filing evidence
2022-01-01 – 2022-12-312828000 USD20240328Open filing evidence

Operating Segments · US · Dermatology Procedures Equipment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-311012000 USD20260326Open filing evidence
2025-07-01 – 2025-09-30142000 USD20251114Open filing evidence
2025-01-01 – 2025-09-30688000 USD20251114Open filing evidence
2025-04-01 – 2025-06-30397000 USD20250814Open filing evidence
2025-01-01 – 2025-06-30546000 USD20250814Open filing evidence
2024-01-01 – 2024-12-311357000 USD20260326Open filing evidence
2024-07-01 – 2024-09-30677000 USD20251114Open filing evidence
2024-01-01 – 2024-09-301275000 USD20251114Open filing evidence
2024-04-01 – 2024-06-30458000 USD20250814Open filing evidence
2024-01-01 – 2024-06-30598000 USD20250814Open filing evidence

Operating Segments · US · Dermatology Recurring Procedures

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3119572000 USD20260326Open filing evidence
2025-07-01 – 2025-09-305076000 USD20251114Open filing evidence
2025-01-01 – 2025-09-3013987000 USD20251114Open filing evidence
2025-04-01 – 2025-06-304663000 USD20250814Open filing evidence
2025-01-01 – 2025-06-308911000 USD20250814Open filing evidence
2024-01-01 – 2024-12-3119531000 USD20260326Open filing evidence
2024-07-01 – 2024-09-304893000 USD20251114Open filing evidence
2024-01-01 – 2024-09-3014136000 USD20251114Open filing evidence
2024-04-01 – 2024-06-304923000 USD20250814Open filing evidence
2024-01-01 – 2024-06-309243000 USD20250814Open filing evidence

Operating Segments · Geographic Distribution Other Foreign · Dermatology Procedures Equipment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-312955000 USD20260326Open filing evidence
2025-07-01 – 2025-09-30939000 USD20251114Open filing evidence
2025-01-01 – 2025-09-301511000 USD20251114Open filing evidence
2025-04-01 – 2025-06-30181000 USD20250814Open filing evidence
2025-01-01 – 2025-06-30572000 USD20250814Open filing evidence
2024-01-01 – 2024-12-314199000 USD20260326Open filing evidence
2024-07-01 – 2024-09-30970000 USD20251114Open filing evidence
2024-01-01 – 2024-09-302692000 USD20251114Open filing evidence
2024-04-01 – 2024-06-301336000 USD20250814Open filing evidence
2024-01-01 – 2024-06-301722000 USD20250814Open filing evidence
2022-01-01 – 2022-12-313356000 USD20240328Open filing evidence

Operating Segments · Geographic Distribution Other Foreign · Dermatology Recurring Procedures

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-311906000 USD20260326Open filing evidence
2025-07-01 – 2025-09-30470000 USD20251114Open filing evidence
2025-01-01 – 2025-09-301405000 USD20251114Open filing evidence
2025-04-01 – 2025-06-30456000 USD20250814Open filing evidence
2025-01-01 – 2025-06-30935000 USD20250814Open filing evidence
2024-01-01 – 2024-12-311640000 USD20260326Open filing evidence
2024-07-01 – 2024-09-30488000 USD20251114Open filing evidence
2024-01-01 – 2024-09-301280000 USD20251114Open filing evidence
2024-04-01 – 2024-06-30416000 USD20250814Open filing evidence
2024-01-01 – 2024-06-30792000 USD20250814Open filing evidence
2023-01-01 – 2023-12-31642000 USD20240328Open filing evidence

Operating Segments · Geographic Distribution Domestic · Dermatology Procedures Equipment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-06-301422000 USD20240814Open filing evidence

Operating Segments · Geographic Distribution Domestic · Dermatology Recurring Procedures

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3120215000 USD20240328Open filing evidence
2023-07-01 – 2023-09-304960000 USD20241114Open filing evidence

Operating Segments · Geographic Distribution Foreign · Dermatology Procedures Equipment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-311917000 USD20240515Open filing evidence

Operating Segments · Middle East · Dermatology Procedures Equipment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-311896000 USD20260326Open filing evidence
2025-07-01 – 2025-09-30172000 USD20251114Open filing evidence
2025-01-01 – 2025-09-301190000 USD20251114Open filing evidence
2025-04-01 – 2025-06-30307000 USD20250814Open filing evidence
2025-01-01 – 2025-06-301018000 USD20250814Open filing evidence
2024-01-01 – 2024-12-312766000 USD20260326Open filing evidence
2024-07-01 – 2024-09-30724000 USD20251114Open filing evidence
2024-01-01 – 2024-09-301438000 USD20251114Open filing evidence
2024-04-01 – 2024-06-30284000 USD20250814Open filing evidence
2024-01-01 – 2024-06-30714000 USD20250814Open filing evidence

Operating Segments · Middle East · Dermatology Recurring Procedures

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-310 USD20260326Open filing evidence
2025-07-01 – 2025-09-300 USD20251114Open filing evidence
2025-01-01 – 2025-09-300 USD20251114Open filing evidence
2025-04-01 – 2025-06-300 USD20250814Open filing evidence
2025-01-01 – 2025-06-300 USD20250814Open filing evidence
2024-01-01 – 2024-12-310 USD20260326Open filing evidence
2024-07-01 – 2024-09-300 USD20251114Open filing evidence
2024-01-01 – 2024-09-300 USD20251114Open filing evidence
2024-04-01 – 2024-06-300 USD20250814Open filing evidence
2024-01-01 – 2024-06-300 USD20250814Open filing evidence

Operating Segments · CN · Dermatology Procedures Equipment

Consolidation Items · Geographic Distribution · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-314556000 USD20230331Open filing evidence

Operating Segments · Geographic Distribution Domestic · Dermatology Procedures Equipment

Consolidation Items · Geographic Distribution · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-302301000 USD20231114Open filing evidence
2023-01-01 – 2023-06-301422000 USD20230809Open filing evidence
2022-04-01 – 2022-06-30547000 USD20220810Open filing evidence
2022-01-01 – 2022-03-31695000 USD20230515Open filing evidence

Operating Segments · Geographic Distribution Domestic · Dermatology Recurring Procedures

Consolidation Items · Geographic Distribution · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-06-309866000 USD20230809Open filing evidence
2022-01-01 – 2022-03-314689000 USD20230515Open filing evidence
2021-01-01 – 2021-06-309553000 USD20220810Open filing evidence

Operating Segments · Geographic Distribution Foreign · Dermatology Procedures Equipment

Consolidation Items · Geographic Distribution · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-311862000 USD20230515Open filing evidence
2022-01-01 – 2022-09-307249000 USD20221109Open filing evidence
2022-01-01 – 2022-06-304255000 USD20220810Open filing evidence
2021-01-01 – 2021-12-315467000 USD20220321Open filing evidence
2021-01-01 – 2021-03-31890000 USD20220511Open filing evidence

Operating Segments · Geographic Distribution Foreign · Dermatology Recurring Procedures

Consolidation Items · Geographic Distribution · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-09-301103000 USD20231114Open filing evidence
2022-04-01 – 2022-06-30405000 USD20220810Open filing evidence
2021-01-01 – 2021-06-30578000 USD20220810Open filing evidence

Operating Segments · Dermatology Imaging

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-310 USD20191030Open filing evidence

Operating Segments · Dermatology Procedures Equipment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-319218000 USD20260326Open filing evidence
2025-07-01 – 2025-09-301383000 USD20251114Open filing evidence
2025-01-01 – 2025-09-306012000 USD20251114Open filing evidence
2025-04-01 – 2025-06-302544000 USD20250814Open filing evidence
2025-01-01 – 2025-06-304629000 USD20250814Open filing evidence
2025-01-01 – 2025-03-312085000 USD20250515Open filing evidence
2024-01-01 – 2024-12-3112391000 USD20260326Open filing evidence
2024-07-01 – 2024-09-303416000 USD20251114Open filing evidence
2024-01-01 – 2024-09-308570000 USD20251114Open filing evidence
2024-04-01 – 2024-06-303096000 USD20250814Open filing evidence
2024-01-01 – 2024-06-305154000 USD20250814Open filing evidence
2024-01-01 – 2024-03-312058000 USD20250515Open filing evidence
2023-07-01 – 2023-09-303572000 USD20231114Open filing evidence
2023-01-01 – 2023-09-308724000 USD20231114Open filing evidence
2023-04-01 – 2023-06-302794000 USD20230809Open filing evidence
2023-01-01 – 2023-06-305152000 USD20240814Open filing evidence
2023-01-01 – 2023-03-312358000 USD20240515Open filing evidence
2022-01-01 – 2022-12-3113136000 USD20230331Open filing evidence
2022-01-01 – 2022-09-309063000 USD20231114Open filing evidence
2022-04-01 – 2022-06-303523000 USD20220810Open filing evidence
2022-01-01 – 2022-06-305497000 USD20230809Open filing evidence
2021-01-01 – 2021-12-317449000 USD20230331Open filing evidence
2021-07-01 – 2021-09-302001000 USD20211112Open filing evidence
2021-01-01 – 2021-09-305079000 USD20221109Open filing evidence
2021-04-01 – 2021-06-301930000 USD20210816Open filing evidence
2021-01-01 – 2021-06-303078000 USD20220810Open filing evidence
2021-01-01 – 2021-03-311148000 USD20210513Open filing evidence
2020-01-01 – 2020-12-315681000 USD20220321Open filing evidence
2020-07-01 – 2020-09-301778000 USD20201110Open filing evidence
2020-04-01 – 2020-06-301234000 USD20210816Open filing evidence
2020-01-01 – 2020-06-302263000 USD20200812Open filing evidence
2020-01-01 – 2020-03-311029000 USD20200513Open filing evidence
2019-01-01 – 2019-12-317873000 USD20210325Open filing evidence
2019-07-01 – 2019-09-301489000 USD20191118Open filing evidence
2019-01-01 – 2019-09-305546000 USD20201110Open filing evidence
2019-04-01 – 2019-06-301886000 USD20200812Open filing evidence
2019-01-01 – 2019-06-304057000 USD20191114Open filing evidence
2019-01-01 – 2019-03-312171000 USD20200513Open filing evidence
2018-01-01 – 2018-12-318802000 USD20191030Open filing evidence
2018-07-01 – 2018-09-302336000 USD20191118Open filing evidence
2018-01-01 – 2018-09-306671000 USD20181114Open filing evidence
2018-04-01 – 2018-06-302366000 USD20191114Open filing evidence
2018-01-01 – 2018-06-304334000 USD20180814Open filing evidence
2017-01-01 – 2017-12-318792000 USD20191030Open filing evidence
2017-07-01 – 2017-09-301751000 USD20181114Open filing evidence
2017-01-01 – 2017-09-305784000 USD20181114Open filing evidence
2017-04-01 – 2017-06-302500000 USD20180814Open filing evidence
2017-01-01 – 2017-06-304041000 USD20180814Open filing evidence

Operating Segments · Dermatology Procedures Equipment · US

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-312813000 USD20250328Open filing evidence

Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Other Foreign

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-316965000 USD20250328Open filing evidence

Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Domestic

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30879000 USD20241114Open filing evidence
2023-01-01 – 2023-09-302301000 USD20241114Open filing evidence
2023-04-01 – 2023-06-30926000 USD20240814Open filing evidence
2023-01-01 – 2023-03-31496000 USD20240515Open filing evidence

Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Foreign

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-09-307295000 USD20241114Open filing evidence
2023-04-01 – 2023-06-301868000 USD20240814Open filing evidence

Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Other Foreign

Consolidation Items · Statement Business Segments · Geographic Distribution

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-313356000 USD20230331Open filing evidence

Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Domestic

Consolidation Items · Statement Business Segments · Geographic Distribution

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30572000 USD20221109Open filing evidence
2021-04-01 – 2021-06-30336000 USD20220810Open filing evidence

Operating Segments · Dermatology Procedures Equipment · Geographic Distribution Foreign

Consolidation Items · Statement Business Segments · Geographic Distribution

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-302693000 USD20231114Open filing evidence
2021-04-01 – 2021-06-301594000 USD20220810Open filing evidence
2021-01-01 – 2021-06-302484000 USD20220810Open filing evidence

Operating Segments · Dermatology Recurring Procedures

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3121478000 USD20260326Open filing evidence
2025-07-01 – 2025-09-305546000 USD20251114Open filing evidence
2025-01-01 – 2025-09-3015392000 USD20251114Open filing evidence
2025-04-01 – 2025-06-305119000 USD20250814Open filing evidence
2025-01-01 – 2025-06-309846000 USD20250814Open filing evidence
2024-01-01 – 2024-12-3121171000 USD20260326Open filing evidence
2024-07-01 – 2024-09-305381000 USD20251114Open filing evidence
2024-01-01 – 2024-09-3015416000 USD20251114Open filing evidence
2024-04-01 – 2024-06-305339000 USD20250814Open filing evidence
2024-01-01 – 2024-06-3010035000 USD20250814Open filing evidence
2023-01-01 – 2023-12-3121530000 USD20250328Open filing evidence
2023-07-01 – 2023-09-305280000 USD20231114Open filing evidence
2023-01-01 – 2023-09-3015945000 USD20241114Open filing evidence
2023-04-01 – 2023-06-305456000 USD20240814Open filing evidence
2023-01-01 – 2023-06-3010665000 USD20240814Open filing evidence
2022-01-01 – 2022-12-3123025000 USD20240328Open filing evidence
2022-07-01 – 2022-09-305847000 USD20231114Open filing evidence
2022-01-01 – 2022-09-3016496000 USD20231114Open filing evidence
2022-01-01 – 2022-06-3010649000 USD20220810Open filing evidence
2022-01-01 – 2022-03-315067000 USD20220511Open filing evidence
2021-01-01 – 2021-12-3122528000 USD20230331Open filing evidence
2021-01-01 – 2021-09-3015841000 USD20221109Open filing evidence
2021-04-01 – 2021-06-305452000 USD20220810Open filing evidence
2021-01-01 – 2021-06-3010131000 USD20220810Open filing evidence
2021-01-01 – 2021-03-314679000 USD20220511Open filing evidence
2020-07-01 – 2020-09-303835000 USD20211112Open filing evidence
2020-01-01 – 2020-09-3012332000 USD20211112Open filing evidence
2020-04-01 – 2020-06-302796000 USD20200812Open filing evidence
2020-01-01 – 2020-06-308497000 USD20210816Open filing evidence
2020-01-01 – 2020-03-315701000 USD20210513Open filing evidence
2019-01-01 – 2019-12-3123713000 USD20200317Open filing evidence
2019-01-01 – 2019-09-3017142000 USD20201110Open filing evidence
2019-04-01 – 2019-06-305839000 USD20200812Open filing evidence
2019-01-01 – 2019-06-3011151000 USD20191114Open filing evidence
2019-01-01 – 2019-03-315312000 USD20191108Open filing evidence
2017-01-01 – 2017-12-3122954000 USD20191030Open filing evidence
2017-01-01 – 2017-09-3017051000 USD20181114Open filing evidence
2017-04-01 – 2017-06-305971000 USD20180814Open filing evidence

Operating Segments · Dermatology Recurring Procedures · CN

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=country:CN
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-310 USD20250328Open filing evidence
2024-01-01 – 2024-03-310 USD20250515Open filing evidence

Operating Segments · Dermatology Recurring Procedures · US

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-314248000 USD20250515Open filing evidence

Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Other Foreign

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31479000 USD20250515Open filing evidence
2022-01-01 – 2022-12-31357000 USD20240328Open filing evidence

Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Domestic

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-304923000 USD20240814Open filing evidence
2024-01-01 – 2024-03-314320000 USD20240515Open filing evidence

Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Foreign

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-30315000 USD20240814Open filing evidence

Operating Segments · Dermatology Recurring Procedures · CN

Consolidation Items · Statement Business Segments · Geographic Distribution

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=country:CN
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31195000 USD20230331Open filing evidence

Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Domestic

Consolidation Items · Statement Business Segments · Geographic Distribution

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-09-3015393000 USD20231114Open filing evidence
2022-04-01 – 2022-06-305177000 USD20230809Open filing evidence
2021-01-01 – 2021-12-3121215000 USD20230331Open filing evidence
2021-04-01 – 2021-06-305127000 USD20220810Open filing evidence

Operating Segments · Dermatology Recurring Procedures · Geographic Distribution Foreign

Consolidation Items · Statement Business Segments · Geographic Distribution

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-31378000 USD20230515Open filing evidence
2021-01-01 – 2021-09-30918000 USD20221109Open filing evidence

CN · Operating Segments · Dermatology Procedures Equipment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:CN;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31834000 USD20250515Open filing evidence
2023-01-01 – 2023-12-313340000 USD20240328Open filing evidence
2022-01-01 – 2022-12-314556000 USD20240328Open filing evidence

CN · Dermatology Procedures Equipment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-313340000 USD20250328Open filing evidence

CN · Dermatology Recurring Procedures · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-310 USD20250515Open filing evidence
2022-01-01 – 2022-12-31195000 USD20240328Open filing evidence

KR · Dermatology Recurring Procedures · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:KR;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31888000 USD20240328Open filing evidence

US · Operating Segments · Dermatology Procedures Equipment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-311357000 USD20250328Open filing evidence

US · Operating Segments · Dermatology Recurring Procedures

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-314320000 USD20250515Open filing evidence

US · Dermatology Procedures Equipment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31149000 USD20250515Open filing evidence

US · Dermatology Recurring Procedures · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3120215000 USD20250328Open filing evidence

Geographic Distribution Other Foreign · Operating Segments · Dermatology Procedures Equipment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31385000 USD20250515Open filing evidence

Geographic Distribution Other Foreign · Dermatology Procedures Equipment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-315675000 USD20250328Open filing evidence

Geographic Distribution Other Foreign · Dermatology Recurring Procedures · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-311640000 USD20250328Open filing evidence
2023-01-01 – 2023-12-311315000 USD20250328Open filing evidence

Geographic Distribution Domestic · Operating Segments · Dermatology Procedures Equipment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-30677000 USD20241114Open filing evidence
2024-01-01 – 2024-09-301275000 USD20241114Open filing evidence
2024-01-01 – 2024-03-31141000 USD20240515Open filing evidence

Geographic Distribution Domestic · Operating Segments · Dermatology Recurring Procedures

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-304893000 USD20241114Open filing evidence
2024-01-01 – 2024-09-3014136000 USD20241114Open filing evidence
2024-01-01 – 2024-06-309243000 USD20240814Open filing evidence
2023-04-01 – 2023-06-305141000 USD20240814Open filing evidence
2022-01-01 – 2022-12-3121585000 USD20240328Open filing evidence

Geographic Distribution Domestic · Dermatology Recurring Procedures · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-3014948000 USD20241114Open filing evidence
2023-01-01 – 2023-06-309988000 USD20240814Open filing evidence

Geographic Distribution Foreign · Operating Segments · Dermatology Procedures Equipment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-302739000 USD20241114Open filing evidence
2024-04-01 – 2024-06-302638000 USD20240814Open filing evidence
2023-01-01 – 2023-06-303730000 USD20240814Open filing evidence

Geographic Distribution Foreign · Operating Segments · Dermatology Recurring Procedures

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-09-301280000 USD20241114Open filing evidence
2024-01-01 – 2024-03-31376000 USD20240515Open filing evidence
2023-07-01 – 2023-09-30320000 USD20241114Open filing evidence

Geographic Distribution Foreign · Dermatology Procedures Equipment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-306423000 USD20241114Open filing evidence
2023-01-01 – 2023-03-311862000 USD20240515Open filing evidence

Geographic Distribution Foreign · Dermatology Recurring Procedures · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-30416000 USD20240814Open filing evidence
2023-01-01 – 2023-03-31362000 USD20240515Open filing evidence

Middle East · Operating Segments · Dermatology Procedures Equipment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31711000 USD20250515Open filing evidence

Middle East · Operating Segments · Dermatology Recurring Procedures

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-310 USD20250515Open filing evidence

Middle East · Dermatology Procedures Equipment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31430000 USD20250515Open filing evidence

Middle East · Dermatology Recurring Procedures · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=us-gaap:MiddleEastMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-310 USD20250515Open filing evidence

Operating Segments · Dermatology Imaging

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyImagingMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-30101000 USD20151116Open filing evidence
2015-01-01 – 2015-09-30239000 USD20151116Open filing evidence
2014-01-01 – 2014-09-30541000 USD20151116Open filing evidence

Operating Segments · Dermatology Procedures Equipment

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2015-01-01 – 2015-09-301638000 USD20151116Open filing evidence
2014-07-01 – 2014-09-300 USD20151116Open filing evidence
2014-01-01 – 2014-09-300 USD20151116Open filing evidence

Operating Segments · Dermatology Recurring Procedures

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-307033000 USD20151116Open filing evidence
2015-01-01 – 2015-09-307138000 USD20151116Open filing evidence
2014-01-01 – 2014-09-300 USD20151116Open filing evidence

Operating Segments · Dermatology Imaging

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-3117000 USD20180402Open filing evidence
2017-07-01 – 2017-09-309000 USD20171114Open filing evidence
2017-01-01 – 2017-06-308000 USD20170811Open filing evidence
2017-01-01 – 2017-03-314000 USD20180515Open filing evidence
2016-01-01 – 2016-12-31134000 USD20180402Open filing evidence
2016-07-01 – 2016-09-3012000 USD20171114Open filing evidence
2016-01-01 – 2016-09-30126000 USD20161114Open filing evidence
2016-01-01 – 2016-06-30114000 USD20170811Open filing evidence
2016-01-01 – 2016-03-31102000 USD20160516Open filing evidence
2015-01-01 – 2015-12-31288000 USD20160315Open filing evidence
2015-07-01 – 2015-09-30101000 USD20161114Open filing evidence
2015-01-01 – 2015-09-30239000 USD20161114Open filing evidence
2015-01-01 – 2015-03-3181000 USD20160516Open filing evidence

Operating Segments · Dermatology Procedures Equipment

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-311968000 USD20180515Open filing evidence
2017-01-01 – 2017-09-305784000 USD20171114Open filing evidence
2017-04-01 – 2017-06-302496000 USD20170811Open filing evidence
2017-01-01 – 2017-03-311537000 USD20180515Open filing evidence
2016-01-01 – 2016-12-317065000 USD20170313Open filing evidence
2016-07-01 – 2016-09-301550000 USD20171114Open filing evidence
2016-01-01 – 2016-09-305174000 USD20171114Open filing evidence
2016-04-01 – 2016-06-301634000 USD20170811Open filing evidence
2016-01-01 – 2016-06-303624000 USD20160812Open filing evidence
2016-01-01 – 2016-03-311990000 USD20170515Open filing evidence
2015-01-01 – 2015-06-30449000 USD20160812Open filing evidence
2015-01-01 – 2015-03-310 USD20160516Open filing evidence
2014-01-01 – 2014-12-310 USD20160315Open filing evidence

Operating Segments · Dermatology Recurring Procedures

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-3122640000 USD20180402Open filing evidence
2017-07-01 – 2017-09-305720000 USD20171114Open filing evidence
2017-01-01 – 2017-09-3017653000 USD20171114Open filing evidence
2017-01-01 – 2017-06-3011933000 USD20170811Open filing evidence
2017-01-01 – 2017-03-315556000 USD20180515Open filing evidence
2016-07-01 – 2016-09-306205000 USD20161114Open filing evidence
2016-01-01 – 2016-09-3017826000 USD20161114Open filing evidence
2016-04-01 – 2016-06-306093000 USD20170811Open filing evidence
2016-01-01 – 2016-06-3011621000 USD20160812Open filing evidence
2016-01-01 – 2016-03-315528000 USD20160516Open filing evidence
2015-01-01 – 2015-12-3114616000 USD20170313Open filing evidence
2015-07-01 – 2015-09-307033000 USD20161114Open filing evidence
2015-01-01 – 2015-09-307138000 USD20161114Open filing evidence
2015-01-01 – 2015-06-30104000 USD20160812Open filing evidence
2014-01-01 – 2014-12-310 USD20160315Open filing evidence

CN · Dermatology Procedures Equipment · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=country:CN;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31931000 USD20230331Open filing evidence

KR · Dermatology Procedures Equipment · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=country:KR;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-312412000 USD20230331Open filing evidence

Geographic Distribution Other Foreign · Dermatology Procedures Equipment · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-312124000 USD20230331Open filing evidence

Geographic Distribution Other Foreign · Dermatology Recurring Procedures · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31357000 USD20230331Open filing evidence

Geographic Distribution Domestic · Operating Segments · Dermatology Procedures Equipment

Geographic Distribution · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30572000 USD20231114Open filing evidence
2022-01-01 – 2022-09-301814000 USD20221109Open filing evidence
2022-01-01 – 2022-06-301242000 USD20230809Open filing evidence
2022-01-01 – 2022-03-31695000 USD20220511Open filing evidence

Geographic Distribution Domestic · Operating Segments · Dermatology Recurring Procedures

Geographic Distribution · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-3121215000 USD20220321Open filing evidence
2021-01-01 – 2021-09-3014923000 USD20221109Open filing evidence

Geographic Distribution Domestic · Dermatology Procedures Equipment

Geographic Distribution · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-09-301113000 USD20211112Open filing evidence
2021-04-01 – 2021-06-30336000 USD20210816Open filing evidence
2021-01-01 – 2021-06-30594000 USD20210816Open filing evidence
2021-01-01 – 2021-03-31258000 USD20210513Open filing evidence
2020-07-01 – 2020-09-30261000 USD20211112Open filing evidence
2020-01-01 – 2020-09-30701000 USD20211112Open filing evidence
2020-04-01 – 2020-06-30125000 USD20200812Open filing evidence
2020-01-01 – 2020-06-30440000 USD20210816Open filing evidence
2020-01-01 – 2020-03-31315000 USD20210513Open filing evidence
2019-01-01 – 2019-12-311243000 USD20210325Open filing evidence
2019-07-01 – 2019-09-30241000 USD20201110Open filing evidence
2019-01-01 – 2019-09-30943000 USD20191118Open filing evidence
2019-04-01 – 2019-06-30378000 USD20200812Open filing evidence
2019-01-01 – 2019-06-30702000 USD20200812Open filing evidence
2019-01-01 – 2019-03-31324000 USD20200513Open filing evidence
2018-01-01 – 2018-12-312026000 USD20200317Open filing evidence
2018-07-01 – 2018-09-30366000 USD20191118Open filing evidence
2018-01-01 – 2018-09-301337000 USD20191118Open filing evidence
2018-04-01 – 2018-06-30313000 USD20191114Open filing evidence
2018-01-01 – 2018-06-30970000 USD20191114Open filing evidence
2017-07-01 – 2017-09-30617000 USD20181114Open filing evidence
2017-01-01 – 2017-09-301959000 USD20181114Open filing evidence

Geographic Distribution Domestic · Dermatology Procedures Equipment · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-31496000 USD20230515Open filing evidence
2021-01-01 – 2021-12-311982000 USD20220321Open filing evidence
2021-07-01 – 2021-09-30519000 USD20221109Open filing evidence
2021-01-01 – 2021-06-30594000 USD20220810Open filing evidence

Geographic Distribution Domestic · Dermatology Recurring Procedures

Geographic Distribution · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-305370000 USD20211112Open filing evidence
2021-04-01 – 2021-06-305127000 USD20210816Open filing evidence
2021-01-01 – 2021-06-309553000 USD20210816Open filing evidence
2021-01-01 – 2021-03-314426000 USD20210513Open filing evidence
2020-07-01 – 2020-09-303690000 USD20211112Open filing evidence
2020-01-01 – 2020-09-3011957000 USD20201110Open filing evidence
2020-04-01 – 2020-06-302670000 USD20210816Open filing evidence
2020-01-01 – 2020-06-308267000 USD20200812Open filing evidence
2020-01-01 – 2020-03-315597000 USD20200513Open filing evidence
2019-01-01 – 2019-12-3123645000 USD20210325Open filing evidence
2019-07-01 – 2019-09-305991000 USD20191118Open filing evidence
2019-01-01 – 2019-09-3017142000 USD20191118Open filing evidence
2019-04-01 – 2019-06-305839000 USD20200812Open filing evidence
2019-01-01 – 2019-06-3011151000 USD20191114Open filing evidence
2019-01-01 – 2019-03-315312000 USD20200513Open filing evidence
2018-01-01 – 2018-12-3121053000 USD20191030Open filing evidence
2018-07-01 – 2018-09-305393000 RestatedUSD20191118Open filing evidence
2018-04-01 – 2018-06-305022000 RestatedUSD20191114Open filing evidence
2018-01-01 – 2018-06-309665000 USD20180814Open filing evidence
2017-01-01 – 2017-12-3122954000 USD20191030Open filing evidence
2017-07-01 – 2017-09-305525000 USD20181114Open filing evidence
2017-04-01 – 2017-06-305971000 USD20180814Open filing evidence

Geographic Distribution Domestic · Dermatology Recurring Procedures · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-305177000 USD20220810Open filing evidence

Geographic Distribution Foreign · Operating Segments · Dermatology Procedures Equipment

Geographic Distribution · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-302976000 USD20230809Open filing evidence
2022-01-01 – 2022-03-311279000 USD20230515Open filing evidence
2021-01-01 – 2021-09-303966000 USD20221109Open filing evidence

Geographic Distribution Foreign · Operating Segments · Dermatology Recurring Procedures

Geographic Distribution · Consolidation Items · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-30997000 USD20231114Open filing evidence
2023-01-01 – 2023-06-30677000 USD20230809Open filing evidence
2022-07-01 – 2022-09-30320000 USD20221109Open filing evidence
2022-01-01 – 2022-06-30783000 USD20230809Open filing evidence
2021-01-01 – 2021-12-311313000 USD20220321Open filing evidence
2021-04-01 – 2021-06-30325000 USD20220810Open filing evidence
2021-01-01 – 2021-03-31253000 USD20220511Open filing evidence

Geographic Distribution Foreign · Dermatology Procedures Equipment And Imaging

Geographic Distribution · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentAndImagingMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-315271000 USD20191030Open filing evidence

Geographic Distribution Foreign · Dermatology Procedures Equipment

Geographic Distribution · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-301482000 USD20211112Open filing evidence
2021-04-01 – 2021-06-301594000 USD20210816Open filing evidence
2021-01-01 – 2021-03-31890000 USD20210513Open filing evidence
2020-01-01 – 2020-06-301823000 USD20210816Open filing evidence
2020-01-01 – 2020-03-31714000 USD20210513Open filing evidence
2019-01-01 – 2019-09-304603000 USD20201110Open filing evidence
2019-01-01 – 2019-06-303355000 USD20191114Open filing evidence
2019-01-01 – 2019-03-311847000 USD20200513Open filing evidence
2018-01-01 – 2018-12-316776000 USD20191030Open filing evidence
2018-07-01 – 2018-09-301970000 USD20181114Open filing evidence
2018-01-01 – 2018-06-303364000 USD20180814Open filing evidence

Geographic Distribution Foreign · Dermatology Procedures Equipment · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-301868000 USD20230809Open filing evidence
2022-04-01 – 2022-06-302976000 USD20220810Open filing evidence
2022-01-01 – 2022-06-304255000 USD20230809Open filing evidence
2021-07-01 – 2021-09-301482000 USD20221109Open filing evidence
2020-01-01 – 2020-12-314725000 USD20220321Open filing evidence

Geographic Distribution Foreign · Dermatology Recurring Procedures

Geographic Distribution · Statement Business Segments

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-30340000 USD20211112Open filing evidence
2021-01-01 – 2021-09-30918000 USD20211112Open filing evidence
2020-01-01 – 2020-09-30375000 USD20201110Open filing evidence
2020-04-01 – 2020-06-30126000 USD20210816Open filing evidence
2020-01-01 – 2020-03-31104000 USD20210513Open filing evidence
2019-01-01 – 2019-12-3168000 USD20210325Open filing evidence
2019-07-01 – 2019-09-300 USD20201110Open filing evidence
2019-01-01 – 2019-09-300 USD20201110Open filing evidence
2019-04-01 – 2019-06-300 USD20200812Open filing evidence
2019-01-01 – 2019-06-300 USD20200812Open filing evidence
2019-01-01 – 2019-03-310 USD20200513Open filing evidence
2018-01-01 – 2018-12-310 USD20200317Open filing evidence
2018-07-01 – 2018-09-300 USD20191118Open filing evidence
2018-01-01 – 2018-09-300 USD20191118Open filing evidence
2018-04-01 – 2018-06-300 USD20191114Open filing evidence
2018-01-01 – 2018-06-300 USD20191114Open filing evidence
2018-01-01 – 2018-03-310 USD20191108Open filing evidence
2017-01-01 – 2017-12-310 USD20191030Open filing evidence
2017-07-01 – 2017-09-300 USD20181114Open filing evidence
2017-01-01 – 2017-09-300 USD20181114Open filing evidence
2017-01-01 – 2017-06-300 USD20180814Open filing evidence

Geographic Distribution Foreign · Dermatology Recurring Procedures · Operating Segments

Geographic Distribution · Statement Business Segments · Consolidation Items

Source dimensions us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-31378000 USD20220511Open filing evidence

Dermatology Imaging · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyImagingMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-30218000 USD20151116Open filing evidence

Dermatology Procedures Equipment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-300 USD20151116Open filing evidence
2014-01-01 – 2014-09-300 USD20151116Open filing evidence

Dermatology Procedures Equipment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyProceduresEquipmentMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-301189000 USD20151116Open filing evidence

Dermatology Recurring Procedures

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-300 USD20151116Open filing evidence
2014-01-01 – 2014-09-300 USD20151116Open filing evidence

Dermatology Recurring Procedures · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mela:DermatologyRecurringProceduresMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2014-07-01 – 2014-09-300 USD20151116Open filing evidence

Dermatology Imaging · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-3117000 USD20191030Open filing evidence
2017-07-01 – 2017-09-309000 USD20181114Open filing evidence
2017-01-01 – 2017-09-3017000 USD20181114Open filing evidence

Dermatology Imaging · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyImagingMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-09-3017000 USD20171114Open filing evidence
2017-04-01 – 2017-06-304000 USD20170811Open filing evidence
2017-01-01 – 2017-03-314000 USD20170515Open filing evidence
2016-01-01 – 2016-12-31134000 USD20170313Open filing evidence
2016-01-01 – 2016-09-30126000 USD20171114Open filing evidence
2016-04-01 – 2016-06-3012000 USD20170811Open filing evidence
2016-01-01 – 2016-03-31102000 USD20170515Open filing evidence
2015-01-01 – 2015-12-31288000 USD20170313Open filing evidence
2015-04-01 – 2015-06-3058000 USD20160812Open filing evidence
2015-01-01 – 2015-06-30139000 USD20160812Open filing evidence
2014-01-01 – 2014-12-31915000 USD20160315Open filing evidence

Dermatology Procedures Equipment And Imaging

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentAndImagingMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-318809000 USD20191030Open filing evidence

Dermatology Procedures Equipment And Imaging · Geographic Distribution Domestic

Statement Business Segments · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentAndImagingMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-313538000 USD20191030Open filing evidence

Dermatology Procedures Equipment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-319218000 USD20260326Open filing evidence
2024-01-01 – 2024-12-3112391000 USD20260326Open filing evidence
2023-01-01 – 2023-12-3111828000 USD20250328Open filing evidence
2022-01-01 – 2022-12-3113136000 USD20240328Open filing evidence
2021-01-01 – 2021-12-317449000 USD20230331Open filing evidence
2021-07-01 – 2021-09-302001000 USD20211112Open filing evidence
2021-01-01 – 2021-09-305079000 USD20211112Open filing evidence
2021-04-01 – 2021-06-301930000 USD20210816Open filing evidence
2021-01-01 – 2021-06-303078000 USD20210816Open filing evidence
2021-01-01 – 2021-03-311148000 USD20210513Open filing evidence
2020-01-01 – 2020-12-315681000 USD20220321Open filing evidence
2020-07-01 – 2020-09-301778000 USD20211112Open filing evidence
2020-01-01 – 2020-09-304041000 USD20211112Open filing evidence
2020-04-01 – 2020-06-301234000 USD20210816Open filing evidence
2020-01-01 – 2020-06-302263000 USD20210816Open filing evidence
2020-01-01 – 2020-03-311029000 USD20210513Open filing evidence
2019-01-01 – 2019-12-317837000 RestatedUSD20210325Open filing evidence
2019-07-01 – 2019-09-301489000 USD20201110Open filing evidence
2019-01-01 – 2019-09-305546000 USD20201110Open filing evidence
2019-04-01 – 2019-06-301886000 USD20200812Open filing evidence
2019-01-01 – 2019-06-304057000 USD20200812Open filing evidence
2019-01-01 – 2019-03-312171000 USD20200513Open filing evidence
2018-01-01 – 2018-12-318802000 USD20200317Open filing evidence
2018-07-01 – 2018-09-302366000 USD20191118Open filing evidence
2018-01-01 – 2018-09-306670000 RestatedUSD20191118Open filing evidence
2018-04-01 – 2018-06-302366000 USD20191114Open filing evidence
2018-01-01 – 2018-06-304334000 USD20191114Open filing evidence
2018-01-01 – 2018-03-311968000 USD20191108Open filing evidence
2017-07-01 – 2017-09-301760000 USD20181114Open filing evidence
2017-01-01 – 2017-09-305801000 USD20181114Open filing evidence
2017-04-01 – 2017-06-302500000 USD20180814Open filing evidence
2017-01-01 – 2017-06-304041000 USD20180814Open filing evidence

Dermatology Procedures Equipment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-303416000 USD20241114Open filing evidence
2024-01-01 – 2024-09-308570000 USD20241114Open filing evidence
2023-01-01 – 2023-12-3111828000 USD20250328Open filing evidence
2023-07-01 – 2023-09-303572000 USD20241114Open filing evidence
2023-01-01 – 2023-09-308724000 USD20241114Open filing evidence
2023-04-01 – 2023-06-302794000 USD20240814Open filing evidence
2023-01-01 – 2023-06-305152000 USD20230809Open filing evidence
2023-01-01 – 2023-03-312358000 USD20230515Open filing evidence
2022-01-01 – 2022-12-3113136000 USD20240328Open filing evidence
2022-07-01 – 2022-09-303566000 USD20231114Open filing evidence
2022-01-01 – 2022-09-309063000 USD20221109Open filing evidence
2022-04-01 – 2022-06-303523000 USD20230809Open filing evidence
2022-01-01 – 2022-03-311974000 USD20230515Open filing evidence
2021-01-01 – 2021-12-317449000 USD20220321Open filing evidence
2021-07-01 – 2021-09-302001000 USD20221109Open filing evidence
2021-04-01 – 2021-06-301930000 USD20220810Open filing evidence
2021-01-01 – 2021-03-311148000 USD20220511Open filing evidence
2020-07-01 – 2020-09-301778000 USD20211112Open filing evidence
2020-01-01 – 2020-09-304041000 USD20211112Open filing evidence
2020-04-01 – 2020-06-301234000 USD20200812Open filing evidence
2020-01-01 – 2020-06-302263000 USD20210816Open filing evidence
2020-01-01 – 2020-03-311029000 USD20210513Open filing evidence
2019-01-01 – 2019-12-317873000 USD20200317Open filing evidence
2019-07-01 – 2019-09-301489000 USD20201110Open filing evidence
2019-01-01 – 2019-06-304057000 USD20200812Open filing evidence
2019-01-01 – 2019-03-312171000 USD20191108Open filing evidence
2018-01-01 – 2018-12-318802000 USD20200317Open filing evidence
2018-01-01 – 2018-09-306670000 USD20191118Open filing evidence
2018-04-01 – 2018-06-302366000 USD20180814Open filing evidence
2018-01-01 – 2018-06-304334000 USD20191114Open filing evidence
2018-01-01 – 2018-03-311968000 USD20191108Open filing evidence

Dermatology Procedures Equipment · Operating Segments · CN

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:CN
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-314069000 USD20250328Open filing evidence
2024-01-01 – 2024-03-311102000 USD20250515Open filing evidence

Dermatology Procedures Equipment · Operating Segments · US

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31141000 USD20250515Open filing evidence

Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Other Foreign

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-313620000 USD20240328Open filing evidence

Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Domestic

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-312813000 USD20240328Open filing evidence

Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Foreign

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-302693000 USD20241114Open filing evidence

Dermatology Procedures Equipment · Operating Segments · KR

Statement Business Segments · Consolidation Items · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=country:KR
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-312828000 USD20230331Open filing evidence

Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Domestic

Statement Business Segments · Consolidation Items · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-09-301814000 USD20231114Open filing evidence
2022-04-01 – 2022-06-30547000 USD20230809Open filing evidence
2021-01-01 – 2021-12-311982000 USD20230331Open filing evidence
2021-01-01 – 2021-09-301113000 USD20221109Open filing evidence
2020-01-01 – 2020-12-31956000 USD20220321Open filing evidence

Dermatology Procedures Equipment · Operating Segments · Geographic Distribution Foreign

Statement Business Segments · Consolidation Items · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-06-303730000 USD20230809Open filing evidence
2022-07-01 – 2022-09-302994000 USD20231114Open filing evidence
2022-01-01 – 2022-09-307249000 USD20231114Open filing evidence

Dermatology Procedures Equipment · Geographic Distribution Other Foreign · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31391000 USD20250515Open filing evidence

Dermatology Procedures Equipment · Geographic Distribution Domestic · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-30458000 USD20240814Open filing evidence
2024-01-01 – 2024-06-30598000 USD20240814Open filing evidence
2022-01-01 – 2022-12-312396000 USD20240328Open filing evidence

Dermatology Procedures Equipment · Geographic Distribution Foreign · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-06-304556000 USD20240814Open filing evidence

Dermatology Procedures Equipment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-318792000 USD20180402Open filing evidence
2017-07-01 – 2017-09-301751000 USD20171114Open filing evidence
2017-01-01 – 2017-06-304033000 USD20170811Open filing evidence
2017-01-01 – 2017-03-311537000 USD20170515Open filing evidence
2016-01-01 – 2016-12-317065000 USD20180402Open filing evidence
2016-07-01 – 2016-09-301550000 USD20161114Open filing evidence
2016-01-01 – 2016-09-305174000 USD20161114Open filing evidence
2016-04-01 – 2016-06-301634000 USD20160812Open filing evidence
2016-01-01 – 2016-06-303624000 USD20170811Open filing evidence
2016-01-01 – 2016-03-311990000 USD20160516Open filing evidence
2015-01-01 – 2015-12-313591000 USD20170313Open filing evidence
2015-07-01 – 2015-09-301189000 USD20161114Open filing evidence
2015-01-01 – 2015-09-301638000 USD20161114Open filing evidence
2015-04-01 – 2015-06-30449000 USD20160812Open filing evidence

Dermatology Procedures Equipment · Geographic Distribution Domestic

Statement Business Segments · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-30519000 USD20211112Open filing evidence
2020-01-01 – 2020-12-31956000 USD20210325Open filing evidence
2020-07-01 – 2020-09-30261000 USD20201110Open filing evidence
2020-01-01 – 2020-09-30701000 USD20201110Open filing evidence
2020-04-01 – 2020-06-30125000 USD20210816Open filing evidence
2019-01-01 – 2019-09-30943000 USD20201110Open filing evidence
2019-01-01 – 2019-03-31324000 USD20191108Open filing evidence
2018-01-01 – 2018-03-31657000 USD20191108Open filing evidence
2017-04-01 – 2017-06-30815000 USD20180814Open filing evidence
2017-01-01 – 2017-06-301193000 USD20180814Open filing evidence

Dermatology Procedures Equipment · Geographic Distribution Domestic · Operating Segments

Statement Business Segments · Geographic Distribution · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30879000 USD20231114Open filing evidence
2023-04-01 – 2023-06-30926000 USD20230809Open filing evidence
2022-01-01 – 2022-12-312396000 USD20230331Open filing evidence
2021-01-01 – 2021-03-31258000 USD20220511Open filing evidence

Dermatology Procedures Equipment · Geographic Distribution Foreign

Statement Business Segments · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-09-303966000 USD20211112Open filing evidence
2021-01-01 – 2021-06-302484000 USD20210816Open filing evidence
2020-01-01 – 2020-12-314725000 USD20210325Open filing evidence
2020-07-01 – 2020-09-301517000 USD20211112Open filing evidence
2020-01-01 – 2020-09-303340000 USD20211112Open filing evidence
2020-04-01 – 2020-06-301109000 USD20210816Open filing evidence
2019-01-01 – 2019-12-316630000 USD20210325Open filing evidence
2019-07-01 – 2019-09-301248000 USD20201110Open filing evidence
2019-04-01 – 2019-06-301508000 USD20200812Open filing evidence
2019-01-01 – 2019-06-303355000 USD20200812Open filing evidence
2019-01-01 – 2019-03-311847000 USD20191108Open filing evidence
2018-01-01 – 2018-12-316776000 USD20200317Open filing evidence
2018-07-01 – 2018-09-301970000 USD20191118Open filing evidence
2018-01-01 – 2018-09-305333000 RestatedUSD20191118Open filing evidence
2018-04-01 – 2018-06-302053000 USD20191114Open filing evidence
2018-01-01 – 2018-06-303364000 USD20191114Open filing evidence
2018-01-01 – 2018-03-311311000 USD20191108Open filing evidence
2017-07-01 – 2017-09-301143000 USD20181114Open filing evidence
2017-01-01 – 2017-09-303842000 USD20181114Open filing evidence
2017-04-01 – 2017-06-301685000 USD20180814Open filing evidence
2017-01-01 – 2017-06-302848000 USD20180814Open filing evidence

Dermatology Procedures Equipment · Geographic Distribution Foreign · Operating Segments

Statement Business Segments · Geographic Distribution · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyProceduresEquipmentMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-306423000 USD20231114Open filing evidence
2022-01-01 – 2022-03-311279000 USD20220511Open filing evidence

Dermatology Recurring Procedures

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3121478000 USD20260326Open filing evidence
2024-01-01 – 2024-12-3121171000 USD20260326Open filing evidence
2023-01-01 – 2023-12-3121530000 USD20250328Open filing evidence
2022-01-01 – 2022-12-3123025000 USD20240328Open filing evidence
2021-01-01 – 2021-12-3122528000 USD20230331Open filing evidence
2021-07-01 – 2021-09-305710000 USD20211112Open filing evidence
2021-01-01 – 2021-09-3015841000 USD20211112Open filing evidence
2021-04-01 – 2021-06-305452000 USD20210816Open filing evidence
2021-01-01 – 2021-06-3010131000 USD20210816Open filing evidence
2021-01-01 – 2021-03-314679000 USD20210513Open filing evidence
2020-01-01 – 2020-12-3117409000 USD20220321Open filing evidence
2020-07-01 – 2020-09-303835000 USD20211112Open filing evidence
2020-01-01 – 2020-09-3012332000 USD20211112Open filing evidence
2020-04-01 – 2020-06-302796000 USD20210816Open filing evidence
2020-01-01 – 2020-06-308497000 USD20210816Open filing evidence
2020-01-01 – 2020-03-315701000 USD20210513Open filing evidence
2019-01-01 – 2019-12-3123713000 USD20210325Open filing evidence
2019-07-01 – 2019-09-305991000 USD20201110Open filing evidence
2019-01-01 – 2019-09-3017142000 USD20201110Open filing evidence
2019-04-01 – 2019-06-305839000 USD20200812Open filing evidence
2019-01-01 – 2019-06-3011151000 USD20200812Open filing evidence
2019-01-01 – 2019-03-315312000 USD20200513Open filing evidence
2018-01-01 – 2018-12-3121053000 USD20200317Open filing evidence
2018-07-01 – 2018-09-305393000 RestatedUSD20191118Open filing evidence
2018-01-01 – 2018-09-3015186000 RestatedUSD20191118Open filing evidence
2018-04-01 – 2018-06-305022000 RestatedUSD20191114Open filing evidence
2018-01-01 – 2018-06-309792000 RestatedUSD20191114Open filing evidence
2018-01-01 – 2018-03-314770000 RestatedUSD20191108Open filing evidence
2017-01-01 – 2017-12-3122954000 USD20191030Open filing evidence
2017-07-01 – 2017-09-305525000 USD20181114Open filing evidence
2017-01-01 – 2017-09-3017051000 USD20181114Open filing evidence
2017-04-01 – 2017-06-305971000 USD20180814Open filing evidence
2017-01-01 – 2017-06-3011527000 USD20180814Open filing evidence
2016-01-01 – 2016-03-310 USD20160516Open filing evidence

Dermatology Recurring Procedures · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-314727000 USD20250515Open filing evidence
2024-01-01 – 2024-09-3015416000 USD20241114Open filing evidence
2024-04-01 – 2024-06-305339000 USD20240814Open filing evidence
2024-01-01 – 2024-03-314696000 USD20250515Open filing evidence
2023-01-01 – 2023-12-3121530000 USD20240328Open filing evidence
2023-07-01 – 2023-09-305280000 USD20241114Open filing evidence
2023-04-01 – 2023-06-305456000 USD20230809Open filing evidence
2023-01-01 – 2023-03-315209000 USD20240515Open filing evidence
2022-01-01 – 2022-12-3123025000 USD20230331Open filing evidence
2022-07-01 – 2022-09-305847000 USD20221109Open filing evidence
2022-01-01 – 2022-09-3016496000 USD20221109Open filing evidence
2022-04-01 – 2022-06-305582000 USD20230809Open filing evidence
2022-01-01 – 2022-06-3010649000 USD20230809Open filing evidence
2022-01-01 – 2022-03-315067000 USD20230515Open filing evidence
2021-01-01 – 2021-12-3122528000 USD20220321Open filing evidence
2021-07-01 – 2021-09-305710000 USD20221109Open filing evidence
2021-04-01 – 2021-06-305452000 USD20210816Open filing evidence
2021-01-01 – 2021-06-3010131000 USD20210816Open filing evidence
2020-01-01 – 2020-12-3117409000 USD20220321Open filing evidence
2020-07-01 – 2020-09-303835000 USD20201110Open filing evidence
2020-01-01 – 2020-09-3012332000 USD20201110Open filing evidence
2020-04-01 – 2020-06-302796000 USD20210816Open filing evidence
2019-01-01 – 2019-12-3123713000 USD20210325Open filing evidence
2019-07-01 – 2019-09-305991000 USD20201110Open filing evidence
2019-04-01 – 2019-06-305839000 USD20191114Open filing evidence
2019-01-01 – 2019-06-3011151000 USD20200812Open filing evidence
2019-01-01 – 2019-03-315312000 USD20200513Open filing evidence
2018-01-01 – 2018-12-3121053000 USD20200317Open filing evidence
2018-07-01 – 2018-09-305393000 RestatedUSD20191118Open filing evidence
2018-01-01 – 2018-09-3015186000 RestatedUSD20191118Open filing evidence
2018-04-01 – 2018-06-305022000 RestatedUSD20191114Open filing evidence
2018-01-01 – 2018-06-309792000 RestatedUSD20191114Open filing evidence
2018-01-01 – 2018-03-314770000 USD20191108Open filing evidence
2017-07-01 – 2017-09-305525000 USD20181114Open filing evidence
2017-01-01 – 2017-06-3011527000 USD20180814Open filing evidence

Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Other Foreign

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=sskn:GeographicDistributionOtherForeignMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31376000 USD20250515Open filing evidence

Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Domestic

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-314847000 USD20240515Open filing evidence

Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Foreign

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-06-30792000 USD20240814Open filing evidence
2023-01-01 – 2023-06-30677000 USD20240814Open filing evidence

Dermatology Recurring Procedures · Operating Segments · KR

Statement Business Segments · Consolidation Items · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=country:KR
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31941000 USD20230331Open filing evidence

Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Other Foreign

Statement Business Segments · Consolidation Items · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=sskn:GeographicDistributionOtherForeignMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31372000 USD20230331Open filing evidence

Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Domestic

Statement Business Segments · Consolidation Items · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-304960000 USD20231114Open filing evidence
2023-01-01 – 2023-09-3014948000 USD20231114Open filing evidence
2023-04-01 – 2023-06-305141000 USD20230809Open filing evidence
2022-01-01 – 2022-12-3121585000 USD20230331Open filing evidence
2022-07-01 – 2022-09-305527000 USD20221109Open filing evidence
2021-07-01 – 2021-09-305370000 USD20221109Open filing evidence
2021-01-01 – 2021-03-314426000 USD20220511Open filing evidence

Dermatology Recurring Procedures · Operating Segments · Geographic Distribution Foreign

Statement Business Segments · Consolidation Items · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30320000 USD20231114Open filing evidence
2022-04-01 – 2022-06-30405000 USD20230809Open filing evidence
2021-07-01 – 2021-09-30340000 USD20221109Open filing evidence
2020-01-01 – 2020-12-31561000 USD20220321Open filing evidence

Dermatology Recurring Procedures · KR · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=country:KR;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31673000 USD20240328Open filing evidence

Dermatology Recurring Procedures · Geographic Distribution Foreign · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;srt:StatementGeographicalAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-30488000 USD20241114Open filing evidence
2023-01-01 – 2023-09-30997000 USD20241114Open filing evidence

Dermatology Recurring Procedures · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-314498000 USD20180515Open filing evidence
2017-04-01 – 2017-06-306202000 USD20170811Open filing evidence
2017-01-01 – 2017-03-315731000 USD20170515Open filing evidence
2016-01-01 – 2016-12-3123508000 RestatedUSD20180402Open filing evidence
2016-07-01 – 2016-09-306205000 USD20171114Open filing evidence
2016-01-01 – 2016-09-3017826000 USD20171114Open filing evidence
2016-01-01 – 2016-06-3011621000 USD20170811Open filing evidence
2016-01-01 – 2016-03-315528000 USD20170515Open filing evidence
2015-04-01 – 2015-06-30104000 USD20160812Open filing evidence
2015-01-01 – 2015-03-310 USD20160516Open filing evidence

Dermatology Recurring Procedures · CN · Operating Segments

Statement Business Segments · Geographic Distribution · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=country:CN;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-310 USD20230331Open filing evidence

Dermatology Recurring Procedures · KR · Operating Segments

Statement Business Segments · Geographic Distribution · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=country:KR;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31888000 USD20230331Open filing evidence

Dermatology Recurring Procedures · Geographic Distribution Domestic

Statement Business Segments · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-09-3014923000 USD20211112Open filing evidence
2020-01-01 – 2020-12-3116848000 USD20210325Open filing evidence
2020-01-01 – 2020-09-3011957000 USD20211112Open filing evidence
2020-01-01 – 2020-06-308267000 USD20210816Open filing evidence
2020-01-01 – 2020-03-315597000 USD20210513Open filing evidence
2019-01-01 – 2019-12-3123645000 USD20200317Open filing evidence
2019-07-01 – 2019-09-305991000 USD20201110Open filing evidence
2019-01-01 – 2019-09-3017142000 USD20201110Open filing evidence
2019-01-01 – 2019-06-3011151000 USD20200812Open filing evidence
2018-01-01 – 2018-12-3121053000 USD20200317Open filing evidence
2018-01-01 – 2018-09-3015186000 RestatedUSD20191118Open filing evidence
2018-01-01 – 2018-06-309792000 USD20191114Open filing evidence
2018-01-01 – 2018-03-314770000 RestatedUSD20191108Open filing evidence
2017-01-01 – 2017-09-3017051000 USD20181114Open filing evidence
2017-01-01 – 2017-06-3011527000 USD20180814Open filing evidence

Dermatology Recurring Procedures · Geographic Distribution Domestic · Operating Segments

Statement Business Segments · Geographic Distribution · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionDomesticMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-06-309988000 USD20230809Open filing evidence
2023-01-01 – 2023-03-314847000 USD20230515Open filing evidence
2022-07-01 – 2022-09-305527000 USD20231114Open filing evidence
2022-01-01 – 2022-09-3015393000 USD20221109Open filing evidence
2022-01-01 – 2022-03-314689000 USD20220511Open filing evidence
2020-01-01 – 2020-12-3116848000 USD20220321Open filing evidence

Dermatology Recurring Procedures · Geographic Distribution Foreign

Statement Business Segments · Geographic Distribution

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-30325000 USD20210816Open filing evidence
2021-01-01 – 2021-06-30578000 USD20210816Open filing evidence
2021-01-01 – 2021-03-31253000 USD20210513Open filing evidence
2020-01-01 – 2020-12-31561000 USD20210325Open filing evidence
2020-07-01 – 2020-09-30145000 USD20211112Open filing evidence
2020-01-01 – 2020-09-30375000 USD20211112Open filing evidence
2020-01-01 – 2020-06-30230000 USD20210816Open filing evidence
2019-01-01 – 2019-12-3168000 USD20200317Open filing evidence
2019-01-01 – 2019-09-300 USD20191118Open filing evidence
2019-01-01 – 2019-06-300 USD20191114Open filing evidence
2019-01-01 – 2019-03-310 USD20191108Open filing evidence
2018-07-01 – 2018-09-300 USD20181114Open filing evidence
2018-01-01 – 2018-09-300 USD20181114Open filing evidence
2018-04-01 – 2018-06-300 USD20180814Open filing evidence
2018-01-01 – 2018-06-300 USD20180814Open filing evidence
2018-01-01 – 2018-03-310 USD20180515Open filing evidence
2017-04-01 – 2017-06-300 USD20180814Open filing evidence

Dermatology Recurring Procedures · Geographic Distribution Foreign · Operating Segments

Statement Business Segments · Geographic Distribution · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sskn:DermatologyRecurringProceduresMember;us-gaap:GeographicDistributionAxis=us-gaap:GeographicDistributionForeignMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30320000 USD20231114Open filing evidence
2023-04-01 – 2023-06-30315000 USD20230809Open filing evidence
2023-01-01 – 2023-03-31362000 USD20230515Open filing evidence
2022-01-01 – 2022-09-301103000 USD20221109Open filing evidence